Russia’s Sputnik V vaccine is 92% effective in protecting people from Covid-19 based on interim test results, the country’s sovereign wealth fund said on Wednesday, as Moscow rushes to keep pace with drug makers. Westerners in the rush for an injection. The results from Russia are just the second in …
Read More »Indian Trials of Russian Sputnik-V Vaccine May End in March: Dr. Reddy’s | India News
BENGALURU: Pharmaceutical drugmaker Dr. Reddy’s Laboratories Ltd released a preliminary schedule for Indian trials of Russia’s coronavirus vaccine candidate on Wednesday, with the final stage expected to be completed in March 2021. Israeli Executive Director Erez said enrollment for the Sputnik-V vaccine mid-stage trial will begin in the coming weeks …
Read More »After Sputnik V, Russia Approves Second Covid-19 EpiVacCorona Vaccine; Putin says the third is almost ready
Moscow: Russia has given regulatory approval to a second Covid-19 vaccine, called ‘EpiVacCorona’, after early-stage studies. The new coronavirus vaccine comes two months after a similar move for Russia’s first vaccine, Sputnik V, drew widespread criticism from scientists both at home and abroad. Also Read – Latest COVID-19 Vaccine Update: …
Read More »Coronavirus Vaccine Update: From Oxford Trial Pause to Sinovac’s Good Results, Here Are All Updates on COVID Vaccine Development
Covaxin, India’s first homegrown attempt to fight the pandemic, has undergone rapid testing and is now in the midst of medium-scale testing. According to experts, if all goes well, the deadline for vaccine delivery could be sped up even further and India could see millions of doses ready by early …
Read More »26 scientists in open letter
The letter said the trial showed that multiple participants reported identical antibody levels (representative) Moscow: Twenty-six scientists, most of them working at Italian universities, signed an open letter questioning the reliability of the data presented in the results of the initial trial of the Russian COVID-19 vaccine, called “Sputnik-V”. Addressing …
Read More »Russia Vaccine: Russians Seek Hyderabad Pharmaceutical Company to Launch Sputnik V Vaccine | Hyderabad News
HYDERABAD: Russia, seeking to produce large doses of its Covid-19 Sputnik V vaccine for global supply, is knocking on the doors of vaccine manufacturers in Hyderabad. Representatives of the Russian Direct Investment Fund (RDIF), which has been involved in the development of Sputnik V, has reached out to the city’s …
Read More »India considering Russia’s request for phase 3 trial and covid vaccine production
The Indian government is considering the Russian government’s request to conduct phase 3 trials of the covid Sputnik V vaccine in the country and also to manufacture the vaccine in the country, said Dr. VK Paul, member (health) of NITI Aayog. The Indian government of India attaches great importance to …
Read More »Russia Corona Vaccine: First batch of Russian Sputnik V vaccine released to the public | World News
MOSCOW: The first batch of the Sputnik V vaccine against Covid-19, developed by the Gamaleya National Research Center for Epidemiology and Microbiology of Russia and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, the Regional deliveries are planned in the near future, reports the Russian Ministry …
Read More »Ahead of Sputnik V Covid-19 Vaccine Trial in India, Russia’s Sharp Answers to 6 Key Questions
After Russia broke the news that it had developed the world’s ‘first coronavirus vaccine’ with pomp, hope and questions soared in equal measure among the public that has prepared during the 6 months of the pandemic. Now, the head of Russia’s Direct Investment Fund, Kirill Dmitriev, has said that clinical …
Read More »Russia’s Coronavirus Vaccine ‘Safe’, Passes Preliminary Test: Lancet Study
Russia COVID-19 Vaccine: Russia’s vaccine is called “Sputnik V” and has received approval. London: Patients who participated in the first trials of a Russian coronavirus vaccine developed antibodies without “serious adverse effects,” according to research published in The Lancet on Friday, but experts said the trials were too small to …
Read More »